Key clinical point: A broadly effective treatment for heavy menstrual bleeding was not achieved among young patients with inherited platelet function disorders.
Major finding: About 56% of patients failed initial treatment and required a mean of two additional treatments during follow-up.
Study details: A retrospective chart review was performed of outpatient treatment of 34 patients aged 9-25 years with heavy menstrual bleeding and diagnosed with inherited platelet function disorders.
Disclosures: One of the authors participated in funded trials and received funding from several pharmaceutical companies. The others reported having no disclosures.
Pennesi CM et al. J Pediatr Adolesc Gynecol. 2020 Jun 22. doi: 10.1016/j.jpag.2020.06.019.